is retatrutide bad Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Retatrutide, an experimental weight-loss drug,

5 New drugs are coming

The same mental health issues we see with bariatric surgery, were going to see in psychological weight agents

These results confirm previous work demonstrating that cells can produce active GLP-1 (30, 67) and, further, that active GLP-1 production is amplified in response to a GLP-1R agonist

closer ophthalmic monitoring is advisable in this group, consistent with NICE guidance on type 2 diabetes management Individuals with renal impairment or those prone to volume depletion : Significant gastrointestinal losses increase the risk of AKI

Insulin, which is a peptide hormone, is essential for regulating glucose levels in the body